Drugs Health Pharma

USFDA issues new draft guidance for trials to expand race, ethnicity

In a bid to include an under-represented population, the US drug regulator has advised healthcare firms to improve racial, ethnic and other diversity.

Read More
Drugs Health Pharma

Novo’s end-stage hypertension trial drug fails, $817m impairment loss

Novo Nordisk’s end-stage trial for hypertension drug has failed to meet its primary goal and the Danish multinational has recognised an impairment loss.

Read More
Drugs Health Pharma

Opinion: Ecstasy drug-driven PSTD treatment faces tough questions

MDMA-assisted psychotherapy is a breakthrough in the treatment of PTSD, but without proper monitoring and documentation, we are inviting trouble.

Read More
Drugs Health Pharma

Alcohol claims 2.6 million lives yearly, 209m people are dependent: WHO

About 400 million people globally live with alcohol and drug use disorders and of the total, 209 million people have alcohol dependence, according.

Read More
Drugs Health Pharma

Global fight against trans fats proving successful as more nations join: UN

Fifty-three nations have adopted best practice policies to eliminate trans fats in foods — benefitting 46% of the world’s population, or about 3.7.

Read More
Drugs Health Pharma

Teva to sell generic version of Novo Nordisk’s diabetic drug in US

Israel’s Teva Pharmaceuticals will start selling a generic version of Novo Nordisk’s type 2 diabetic drug Victoza in the US market.

Read More
Drugs Health Pharma

Novo Nordisk to set up $4.1 billion injectables facility in US’s North Carolina

Novo Nordisk, a Danish pharmaceutical multinational, will invest $4.1 billion to build a new factory in the US to make obesity and chronic.

Read More
Drugs Health Pharma

FDA gives nod to Bristol Myer’s colorectal cancer therapy

The US Food and Drug Administration has greenlighted Bristol Myers Squibb’s combination therapy to treat metastatic colorectal cancer in patients with a mutated.

Read More
Drugs Health Pharma

Eli Lilly’s Zepbound resolves sleep apnea in more than half of trial patients 

Tirzepatide, an obesity drug of  Eli Lilly and Company, has helped resolve moderate-to-severe obstructive sleep apnea in 52.% of adult patients in two.

Read More
Climate Health Pharma

A third of world’s largest marine protected areas exploited: Study

A third of the world’s largest marine protected areas (MPAs) are indulging in destructive activities such as industrial fishing, a global study reveals.

Read More
X